Evidence map›Paper›PMID 30709372›Full record

ArticleBMC infectious diseases2019

Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India.

Devendra T Mourya, Pragya D Yadav, Yogesh K Gurav, Prachi G Pardeshi, Anita M Shete, Rajlaxmi Jain, Dinkar D Raval, Kamlesh J Upadhyay, Deepak Y Patil

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Co-Immunization Efficacy of Recombinant Antigens againstPathogens (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Devendra T MouryaICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India. dtmourya@gmail.com.
Pragya D YadavICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
Yogesh K GuravICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
Prachi G PardeshiICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
Anita M SheteICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
Rajlaxmi JainICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
Dinkar D RavalState Health Society, Health and Family Welfare Department, Gandhinagar, Gujarat, India.
Kamlesh J UpadhyayDepartment of Medicine B. J. Medical College, Ahmedabad, Gujarat, India.
Deepak Y PatilICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
ICMR-National Institute of Virology · INB.J. Medical College · INGovernment of Gujarat · IN

Funding

Department of Health Research (DHR), Government of India, New Delhi. ID-13-3-7
6 · The paper itself

Abstract

backgroundCrimean Congo Hemorrhagic Fever (CCHF) is a highly infectious zoonotic disease of humans transmitted by Hyalomma ticks. Earlier studies have shown CCHF seroprevalence in livestock throughout India, yet sporadic outbreaks have been recorded mostly from the Gujarat state of India since 2011. Occupational vulnerability to CCHF for animal handlers, veterinarians, abattoir workers, and healthcare workers has been documented. The current study was planned to determine the seroprevalence of CCHF with an intention to identify the high -risk population and high -risk areas from Gujarat state, India.

methodsBased on the socio-clinical data, the human population of Gujarat was divided into eight categories viz. A: CCHF affected person/house/close contact, B: Neighborhood contacts, C: Animal handlers, D: General population, E: Farmers, F: Abattoir workers, G: Veterinarian, H: Healthcare workers. A total of 4978 human serum samples were collected from 33 districts of Gujarat during year 2015, 2016 and 2017. All the samples were screened for the presence of anti-CCHFV IgG using indigenously developed anti-CCHFV IgG ELISA. Univariate regression analysis was performed to recognize significant risk factors for CCHF seropositivity.

resultsTwenty-five serum samples were found to be positive with an overall CCHF human seropositivity of 0.5% (95% CI 0.30-0.74%). Gender predisposition to CCHF prevalence was observed in males (OR: 2.80; p-value: 0.020). The risk for seropositivity increased sevenfold when a person was in contact or neighbor with a CCHF case (OR 7.02; p-value: < 0.0001). No significant difference in seropositivity was observed within different age groups. Veterinarians, healthcare workers, and control group were found to be seronegative for CCHF.

conclusionsIn-spite of CCHF sporadic outbreaks reported in Gujarat, the seropositivity for CCHF in the state was low as compared to other endemic countries. Males, close contacts and neighbors were identified as a high-risk population for CCHF infection. To recognize the high-risk area, tick screening and animal serosurvey would be a wiser choice. The study also suggests circulation and under diagnoses of CCHFV in the naïve regions of Gujarat.

Indexed as

AdolescentAdultAgedAged, 80 and overAgricultural Workers' DiseasesAnimalsChildChild, PreschoolDisease OutbreaksEnzyme-Linked Immunosorbent AssayFemaleHemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoHumansIndiaInfantCrimean Congo hemorrhagic feverELISAGujaratHumanRisk factorsSerosurveyTicks

Identifiers

PMID30709372
PMCPMC6359815
OpenAlexW2947909260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.